Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Notification of cessation of securities - ICE (ASX:ICE)

To view the notification, download the attached PDF.

INOVIQ - SubB2M/CA15.3 Clinical Validation Data Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

Application for quotation of securities - IMM (ASX:IMM)

To view the application, download the attached PDF.

Immutep - US patent granted for Efti with PD-1 pathway inhibitor (ASX:IMM)

SYDNEY, AUSTRALIA – 27 June 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disea...read more

Immutep - US patent granted for Efti with PD-1 pathway inhibitor (ASX:IMM)

INOVIQ - Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test (ASX:IIQ)

Highlights INOVIQ’s SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The results of a comprehen...read more

Immutep completes underwritten retail entitlement offer (ASX:IMM)

On Wednesday, 31 May 2023, Immutep Limited ACN 009 237 889 (ASX: IMM) (Immutep or the Company) announced a fully underwritten placement to institutional investors (Placement) and 1 for 7.6 pro rata ...read more

Immutep granted US patent for IMP761 agonist LAG-3 antibody (ASX:IMM)

SYDNEY, AUSTRALIA – 20 June 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapiesfor cancer and autoimmune disea...read more

Immutep - Change in substantial holding (ASX:IMM)

To view the announcement, download the attached PDF.

Immutep - Change in substantial holding (ASX:IMM)

To view the announcement, download the attached PDF.

Immutep - Becoming a substantial holder (ASX:IMM)

To view the notice, download the attached PDF.

Immutep - Cleansing Notice (ASX:IMM)

To view the notice, download the attached PDF.

Application for quotation of securities - IMM (ASX:IMM)

To view the application, download the attached PDF.

Immutep letter to ineligible shareholders (ASX:IMM)

To view the announcement, download the attached PDF.

Immutep retail entitlement offer booklet (ASX:IMM)

Immutep Limited ACN 009 237 889 (ASX: IMM) (Immutep) is pleased to announce that it has today despatched a copy of the retail offer booklet (and accompanying personalised entitlement and accept...read more

Viewing: 136 - 150 of 200 Previous | Next